ODX Conjunction Plan9 Nov 2020 19:27
Inevitably, a vaccine was always going to be on the horizon. Its something that everyone working for Omega knew, Avacta knew, Novacyt knew, so on. So in effect, a successful vaccine regarding testing companies only (none treatment) should already off been priced in. The market cap should should have incorporated as stated 'a given' vaccine, whether that was today, tomorrow or next year. Did we (ODX) deserve the drop? Absolutely not. We haven't got a competitive treatment or vaccine in our ammunition, but a test that works in conjunction with the vaccine itself. I'm trying to see the positives here and I believe my theory as to say this could be the blessing in disguise that Omega needed to get things on track.
I'm expecting Colin King to step up his game and be more productive in his communication to investors to reassure us they are working alongside rather than against today's news.
Will not make a price prediction as its impossible to say, AIM loves a roller coaster, but I haven't sold a share and don't plan on selling any either.
All imo, all eyes on the prize